연구동향 분석

비만환자의 조혈모세포이식 후 체중 적용 기준에 따른 Tacrolimus 초기 농도 비교

이수진 배진아 권지은 이연지 윤정이 강진숙 2021년

논문상세정보
인용/피인용
' 비만환자의 조혈모세포이식 후 체중 적용 기준에 따른 Tacrolimus 초기 농도 비교' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Actual body weight
  • Ideal body weight
  • Obesity
  • tacrolimus
  • therapeuticdrugmonitoring
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
1,094 0

0.0%

' 비만환자의 조혈모세포이식 후 체중 적용 기준에 따른 Tacrolimus 초기 농도 비교' 의 참고문헌

  • Weightbased tacrolimus trough concentrations post liver transplant
    Liu Z [2019]
  • Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy : Second Consensus Report
    Brunet M [2019]
  • The Asia-Pacific perspective: redefining obesity and its treatment
  • Tacrolimus 주사에서 경구로 투여 경로 변경 시 용량 설정비율의 변경에 따른 효과 비교
    정지혜 [2013]
  • Tacrolimus use in adult allogeneic stem cell transplant recipients receiving voriconazole : preemptive dose modification and therapeutic drug monitoring
    Trifilio SM [2010]
  • Tacrolimus in adult hematopoietic stem cell transplantation
    Gao Y [2019]
  • Tacrolimus (FK506) and methotrexate as prophylaxis for acute graftversus-host disease in pediatric allogeneic stem cell transplantation
    Yanik G [2000]
  • Relationship between tacrolimus blood concentrations and clinical outcome during the first 4 weeks after SCT in children
    Watanabe N [2010]
  • Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation
    Wong R [2005]
  • Practical considerations in the use of tacrolimus for allogeneic marrow transplantation
  • Practical considerations in the use of intravenous tacrolimus in hematopoietic stem cell transplantation patients. Journal of oncology pharmacy practice
    Bauters T [2015]
  • Pharmacokinetics in obese patients
  • Overweight Kidney Transplant Recipients Are at Risk of Being Overdosed Following Standard Bodyweight-Based Tacrolimus Starting Dose
    Andrews LM [2017]
  • Metabolism of tacrolimus(FK506)and recent topics in clinical pharmacokinetics
    Iwasaki K [2007]
  • Mechanisms of lower maintenance dose of tacrolimus in obese patients
    Sawamoto K [2014]
  • Low mean post-transplantation tacrolimus levels in weeks 2-3 correlate with acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation from related and unrelated donors
    Hagen PA [2019]
  • High initial blood levels of tacrolimus in overweight renal transplant recipients
    Rodrigo E [2005]
  • Gentamicin therapy
    Devine BJ [1974]
  • Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506complexes
    Liu J [1991]
  • Advances in the clinical management of GVHD
    Ferrara JL. [2008]
  • Acute graft-vs-host disease : pathobiology and management
    Goker H [2001]
  • A randomized, open-label pharmacokinetic trial of tacrolimus extended-release dosing in obese de novo kidney transplant recipients